Halaman 3 - Karsinomatosis Dokter Terbaik - TOP-66 dokter

Lebih dari 30 tahun pengalaman dalam imunologi – Dr. Jaunalksne berspesialisasi dalam viroterapi, sebuah pendekatan mutakhir dalam imunologi.

• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulus dari Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada pengobatan viroterapi yang inovatif

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Spesialisasi dalam bedah kanker kompleks, termasuk prosedur pankreas dan saluran empedu di Rumah Sakit Büyük Anadolu.

• Keahlian dalam bedah onkologi dengan fokus pada kanker gastrointestinal
• Melakukan bedah kanker payudara dan tiroid tingkat lanjut
• Terampil dalam teknik bedah bariatrik dan metabolik

Dr. Joseba Rebollo Liceaga memiliki lebih dari 30 tahun keahlian di bidang onkologi, dengan spesialisasi dalam pendekatan pengobatan multidisiplin.

• Memimpin departemen onkologi di berbagai rumah sakit ternama
• Menyusun penelitian tentang elektrokemoterapi
• Spesialis Onkologi Medis di Clínica Universidad de Navarra
• Bekerja saat ini di Quirónsalud Alicante

Spesialis Onkologi Radiasi di Universitas Marmara – salah satu sekolah kedokteran terkemuka di Turki.

• Lulus dari Fakultas Kedokteran Universitas Marmara
• Menyelesaikan pelatihan spesialis dalam Onkologi Radiasi
• Bekerja di Rumah Sakit Emsey – pusat perawatan kanker terkemuka

Dr. Raj telah melakukan 50.000+ operasi kanker selama lebih dari 19 tahun, dengan spesialisasi Bedah Onkologi Payudara dan Toraks di HCG Manavata Cancer Centre.

• Menjalani pelatihan di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Terlibat dalam 200+ uji klinis, termasuk studi fase 1-3
• Profesor untuk Subspesialisasi DNB Bedah Onkologi dan Bedah Payudara
• Berfokus pada peningkatan kualitas hidup pasien di samping pengobatan

Dr. Shruti Kate berspesialisasi dalam pengobatan kanker tingkat lanjut, termasuk imunoterapi dan terapi metronomik. Ia dilatih di Tata Memorial Hospital – pusat kanker terkemuka di India.

• Menjadi ahli dalam kanker paru-paru, payudara, dan ginekologi
• Menjadi anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Mempresentasikan penelitian kanker paru-paru di Konferensi Kanker Paru-paru Dunia
• Menggunakan pendekatan inovatif untuk kasus kanker stadium lanjut

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde adalah spesialis kedokteran nuklir di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir
• Mahir dalam terapi radioiodine dan Lu-177 RN
• Ahli dalam semua jenis pemindaian nuklir dan PET-CT
• Menerbitkan karya ilmiah di berbagai jurnal medis

Ahli onkologi dengan latar belakang akademis yang kuat, mengajar mahasiswa kedokteran dan memimpin penelitian pascasarjana di HM CIOCC.

• Spesialisasi dalam onkologi mulut dan maksilofasial
• Mengajar berbagai mata pelajaran terkait onkologi
• Mengarahkan penelitian pascasarjana dalam onkologi klinis dan terapan
• Membimbing mahasiswa kedokteran dan residen dalam praktik onkologi

Selama lebih dari 20 tahun mendedikasikan diri pada hematologi dan onkologi pediatrik, Dr. Lopez Ibor memimpin Unit Hematologi dan Onkologi Pediatrik di Rumah Sakit HM Montepríncipe.

• Menjadi spesialis dalam tumor tulang dan otak, leukemia, dan penyakit hematologi
• Menempuh pelatihan di University of Maryland dalam bidang Hematologi dan Onkologi Pediatrik
• Menulis berbagai publikasi ilmiah nasional dan internasional
• Sebelumnya mengepalai unit yang sama di Hospital Universitario Clínica San Rafael